Axcelead 정기 webinar 개최 KRCC & SEKISUI MEDICAL 협력
【Upcoming webinar】
[Accelerate and achieve an optimal IND for your project ～ Smart-INDR ～ ]
Date: Thursday, Jan 11, 2024, 16:00 - 17:00 (KST)
Abstract: Are you interested in one-stop service that can support your IND-enabling studies from planning to implementation? There are many obstacles and individual problems to overcome when applying for an IND. To solve these problems, the integrated IND-enabling service, "Smart-INDR is launched. In this seminar, an overview of Smart-INDR and detailed examples of solutions will be introduced. After that, the breakout meeting rooms are also available, where our experts will answer your further and detailed questions.
Speaker:
Fumihiro Jinno
Axcelead Drug Discovery Partners Inc, Applied Regulatory Science Director
Experts in Breakout Room:
Hideo Fukui, PhD, DABT, DJSOT
Axcelead Drug Discovery Partners Inc, Applied Regulatory Science Senior Director/Senior Consultant
Shotaro Miura
Axcelead Drug Discovery Partners Inc, Chemistry, Discovery Science Director
Register Now
https://www.axcelead.com/en/web_seminar/medical/
Axcelead Drug Discovery Partners Inc.
Japan‘s first drug discovery solutions provider established as a spin-off from Japan’s largest pharmaceutical company, Takeda Pharmaceutical.
SEKISUI MEDICAL CO., Ltd.
With over 50 years of experience, we are the leading company in the field of RI-ADME studies.
KRCC Co., Ltd.
Agent of domestic and overseas CROs such as preclinical intro test, in vivo test, metabolites biotransformation, RI compound synthesis, toxicity, and comprehensive for new drug development.
한국비임상시험연구회 (The Korean Society of Nonclinical Study)